PCRX — Pacira Biosciences Share News
0.000.00%
Last trade - 00:00- $878.64m
- $1.04bn
- $726.41m
Brief: Pacira Biosciences Q3 Adjusted Net Income USD 38.2 Million Vs. IBES Estimate USD 34.9 Million
Pacira Biosciences Inc expected to post earnings of 70 cents a share - Earnings Preview
Pacira Biosciences Inc expected to post earnings of 70 cents a share - Earnings Preview
Brief: Pacira Biosciences Appoints Shawn Cross As Chief Financial Officer
Brief: Pacira Biosciences Board Appointed Lauren Riker As Interim Chief Financial Officer
Brief: Doma Perpetual Sends Letter To Board Of Directors Of Pacira Biosciences To Immediately Accelerate And Increase Its Share Buyback Program To Enhance Return To Shareholders
U.S. RESEARCH ROUNDUP-Airbnb, Dollar General, Walmart
Pacira Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Brief: Pacira Biosciences Q2 Cash & Investments USD 404.2 Million
Pacira Biosciences Inc expected to post earnings of 69 cents a share - Earnings Preview
Brief: Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical Environments
U.S. STOCKS ON THE MOVE-Quest Diagnostics, MGM Resorts, Copper miners
U.S. STOCKS ON THE MOVE-Constellation Brands, First Foundation, Repay Holdings
Pacira down on US approval for generic version of its pain management drug
Brief: Pacira Biosciences, Announces Pricing Of $250.0 Million Aggregate Principal Amount Of 2.125% Convertible Senior Notes Due 2029
Brief: Pacira Biosciences, Inc. Announces Proposed Offering Of $250.0 Million Aggregate Principal Amount Of Convertible Senior Notes
Pacira Biosciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: Pacira Biosciences Q1 Adjusted EBITDA USD 44.6 Million Vs. IBES Estimate USD 45.3 Million
Pacira Biosciences Inc expected to post earnings of 62 cents a share - Earnings Preview